NeuroSync Medical Division · Founded in memory of Guardsman Daniel Probyn, 1st Battalion Grenadier Guards, 2007
BUILT FOR THE
BATTLEFIELD.
AVAILABLE TO
EVERYONE.
One processing protocol. Nine patent applications. Two complete product families.
Architecture
TWO TRACKS.
ONE SUPPLY CHAIN.
Every product in both tracks is derived from the same zero-cost ocean feedstock, processed through the same proprietary non-thermal protocol. The compound profile this unlocks — holobiont-intact, native-sulphation fucoidan, living secondary metabolites — is categorically inaccessible under all prior art thermal processing methods.
RAPID
FAMILY
Point-of-wounding stabilisation
Five devices. One protocol. Any soldier. The RAPID Family extends the viable evacuation window from 36 to 68+ minutes without a medic, without a cold chain, without clinical skill. Designed around the doctrinal gap that kills 40% of combat casualties before a medic arrives.
RAPID
HEALTH
Biological regeneration platform
From a zero-cost ocean feedstock, using a proprietary non-thermal processing protocol that no prior art has described, RAPIDHealth can produce a family of biological scaffolds capable of regenerating every tissue the human body contains — starting with the soldier on the battlefield and ending with the Alzheimer's patient in the clinic.
The Distinction
THE HOLOBIONT
INACCESSIBILITY MOAT.
Every prior art protocol uses thermal drying. Thermal drying kills the microbial holobiont, degrades fucoidan sulphation, denatures phlorotannins. The compound profile of the living holobiont is categorically inaccessible under all prior art processing methods.
No competitor can replicate this without building the Bio-Farm cold-processing chain from scratch.
Core thesis
"The ocean has been making this for free for millions of years. Nobody could access it. Until now."
Track 01
THE RAPID
FAMILY.
Five devices. One protocol. Any soldier. Executed in under two minutes. No medic. No cold chain. No clinical skill required.
TXA + sub-anaesthetic ketamine. Self-administered to outer thigh through clothing.
2 seconds · 22 claims NTL-002 RAPIDPlasma Frangible-membrane plasma unit500ml freeze-dried plasma. Bend → crack → shake. No syringe. No clinical skill.
2 minutes · 25 claims NTL-003 RAPIDConnect Pre-primed sterile transfer lineFactory-filled WFI. Dual male Luer lock. Eliminates the last point of failure in field plasma delivery.
22 claims GB2606416.2 RAPIDGauze Holobiont-intact wound packingCold-processed sargassum. Haemostasis + MRSA-active antimicrobial + NF-κB anti-inflammatory. Every other gauze goes silent when the bleeding stops.
TCCC drop-in · Filed March 2026 NTL-004 Derivative RAPIDPatch Civilian vital signs transmitterContinuous vital signs to attending EMT for pre-hospital triage. HEARTBEAT hardware, civilian configured.
No mesh · No autonomous broadcastTrack 02
RAPIDHEALTH
PLATFORM.
MS, Parkinson's, and Alzheimer's. Three diseases. Two hundred million patients. One platform. Three commercial tracks. Same feedstock. Same cold-processing chain.
Biological scaffolds for dermal regeneration, osseous reconstruction, peripheral nerve repair, haemostatic wound management, and multi-tissue integration. From battlefield wound care to civilian reconstructive surgery.
Five anti-cancer mechanisms from native-sulphation fucoidan. Anti-angiogenesis, anti-metastasis, direct tumour killing, Warburg suppression, immune checkpoint potentiation. Published combination data: 6.3× tumour necrosis with BMS-202. The entire oncology literature has been testing the wrong compound.
SIRT6 activation via native fucoidan sulphate esters. Senomorphic activity suppressing IL-6, IL-8, MCP-1. Hair follicle senescence reversal. Skin anti-ageing. +13% median lifespan in Rochester study — using thermally extracted fucoidan. Native comparison not yet done.
Neurodivergence Assessment
iTHINK.
A DSM-5 aligned neurodivergence assessment platform. React Native. 12+ conditions. Biometric data. AES-256-GCM encryption. FHIR R4 interoperability. HIPAA-ready. Pre app store — alpha tested.
Built and functional · Pre-commercial
iThink Platform →Intellectual Property
THE IP
REGISTER.
Nine patent applications across two complete product families. Filed in under thirteen months. One processing protocol is the single inventive step.
| Reference | Product | Filed | Status |
|---|---|---|---|
| NTL-001 | RAPIDPen — dual-chamber TXA + ketamine auto-injector · 22 claims | March 2026 | UK Application Filed |
| NTL-002 | RAPIDPlasma — frangible-membrane plasma delivery · 25 claims | March 2026 | UK Application Filed |
| NTL-003 | RAPIDConnect — pre-primed sterile transfer line · 22 claims | March 2026 | UK Application Filed |
| NTL-004 | SENTINEL / HEARTBEAT / RAPIDPatch — biosensor platform · 22 claims | March 2026 | UK Application Filed |
| GB2606416.2 | RAPIDGauze / RAPIDGel — holobiont wound management | 24 March 2026 | UK Application Filed |
| GB2607398.1 | RAPIDSkin — lyophilised dermal regeneration scaffold | March 2026 | UK Application Filed |
| GB2607402.1 | RAPIDBone — osseous regeneration scaffold, nano-HA composite | March 2026 | UK Application Filed |
| GB2607492.2 | RAPIDNeural — peripheral nerve repair + remyelination platform | March/April 2026 | UK Application Filed |
| GB2607531.7 | RAPIDOncology — five anti-cancer mechanisms · 18 claims | 1 April 2026 | UK Application Filed |
| GB2607558.0 | RAPIDLongevity — SIRT6, senomorphic, hair follicle senescence reversal | 1 April 2026 | UK Application Filed |
| RAPIDSystem | Multi-tissue reconstruction — skin + bone + nerve simultaneously | — | To File |
DEFENCE &
PROCUREMENT
UKDI Innovation Outline submission: 19 May 2026. Full submission: 2 June 2026. £750K–£1.2M. TRL 3→7, 18 months. NDA-protected technical detail available to qualified procurement contacts.